Category Archives: cancer
GIVING THE DIAGNOSIS PART 3
PART THREE OF DIAGNOSIS Cultural Differences Focus on Symptomatic Relief Introduction to Clinical Trials Complementary And Alternative Medicines Overview Media Matters Antidotes For Anecdotes Prognosis And The Future Taking Your Time, Avoid
being told you have cancer
PART 1 BUT FIRST AN OVERVIEW SO YOU KNOW WHAT IS COMING AND CAN TUNE IN EVERY TUESDAY AT NOON PST TO WHEN TUMOR IS THE RUMOR AND CANCER IS THE ANSWER
WHEN YOU SUSPECT THE DIAGNOSIS OF CANCER
SUSPECT THE DIAGNOSIS HI THIS IS DR KEVIN RYAN, PROFESSOR OF MEDICINE AND BOARD CERTIFIED IN BLOOD ( HEMATOLOGY) AND CANCER( ONCOLOGY) AS WELL AS BEING AUTHOR OF THE BOOK
THE ONCOLOGIST
The oncologist This is Dr KEVIN Ryan MD MBA FACP and hematologist oncologist here, medical oncologist professor and retired colonel and cancer survivor and this is when tumor is the
Summary of first 9 lecture part 1
SUMMARY PART 1 Hi DR Ryan here, medical oncologist , PROFESSOR, RETIRED COLONEL AND CANCER SURVIVOR and this is when tumor is the rumor and cancer is the answer. THIS IS
APF530 Superior to Ondansetron in Preventing Chemotherapy-Induced Nausea or Vomiting
APF530 Superior to Ondansetron in Preventing Chemotherapy-Induced Nausea or Vomiting By Chase Doyle November 25, 2015, Volume 6, Issue 21 Clinical Benefit of APF530 vs Standard of Care The APF530 regimen was
FDA Expands Pembrolizumab Label to Include Approval in Initial Treatment of Unresectable or Metastatic Melanoma
FDA Expands Pembrolizumab Label to Include Approval in Initial Treatment of Unresectable or Metastatic Melanoma By The ASCO Post This is HUGE . Prior to this there really was nothing that worked
Penn joins groundbreaking cancer research coalition with $250 million grant
Penn joins groundbreaking cancer research coalition with $250 million grant The Perelman School of Medicine, along with five other peer institutions, has partnered with The Parker Institute for Cancer Immunotherapy to develop
